Autopsy report · NCT04158141

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

“Permanent Administrative Closure”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 3 years 10 months before it stopped.
• 16 participants enrolled.
• Results were posted on the registry 1 year 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

NRG Oncology

Sponsor type

University, hospital or other

Conditions

Pleural Biphasic Mesothelioma; Pleural Epithelioid Mesothelioma; Stage I Pleural Malignant Mesothelioma AJCC v8; Stage IA Pleural Malignant Mesothelioma AJCC v8; Stage IB Pleural Malignant Mesothelioma AJCC v8; Stage II Pleural Malignant Mesothelioma AJCC v8

Interventions

Carboplatin; Cisplatin; Decortication; Intensity-Modulated Radiation Therapy; Pemetrexed; Pemetrexed Disodium

Participants

16

Sites

12

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.